Description: Develop a better understanding of specialty drug trends and their increasing healthcare costs for more than the past decade by attending this webcast. With the introduction of price competition, you will see changes in the market for biosimilar products and patent-protected drugs. For example, the drug Humira will be gaining 10 biosimilar competitors in 2023. Alone, Humira can represent over 20% of total pharmacy spend for health plans. Join us and discover how price competition is a turning point for the pharmaceutical industry and will define its direction for the next decade.

Description: Walk through real-life examples of how artificial intelligence (AI) can be used to drive insights and aide actuaries in improving the management of their company's inforce book of business. Hear a panel of experts go step-by-step through case studies, showing how practitioners leveraged predictive analytics for solutions to tap further into their data and draw improved insights.Leave the session with knowledge of how to partner advanced machine learning techniques with the actuarial skills and insights to better understand policyholders' behavior to more efficiently enable accelerating revenue and further profit realization.

Description: Attendees will see how care coordination and navigation may improve outcomes when integrating across acute and long-term care needs within Medicare and Long-Term Care Insurance products.

Description: In this webinar, the presenters will give a behind the scenes look at how the NAIC ESG was parameterized. They will also share the results of its most recent calibration.

Description: Explore various aspects of the Asian reinsurance market in this webcast. Learn about the landscape within the market as speakers cover key topics like product perspectives, structured solutions and emerging trends and issues. Take an in-depth look at the post COVID-19 impact, as well as regulatory considerations that could affect the Asian reinsurance industry. Secure your spot in this opportunity and dive into the direction of this marketspace.

Description: Become informed about the approach and adverse effects of the regulation of third parties and advance consent by the proposed NAIC Consumer Privacy Protection Model Law #674. You will hear an explanation of the regulation of third parties through their contracts with insurers. Learn specifics on the negative effect on companies contracting with third parties. Find out more about the requirement for advance consent for use of personal data for actuarial and marketing studies, and hear two potential solutions .At the conclusion of this session, you should be able to explain concerns about contracting with third parties for external data under the Model Law and learn potential solutions to using personal data for actuarial and marketing studies.

Description: Session 2G: The Impact of the Current Administration on Public Financing of Health Care - SIPF Section Perspective

Description: Session 7E: Big D Dialogues - The Ultimate Health Actuary Q&A

Description: This session aims to put everything together and explore progress on company’s ERM process to incorporate climate risks and enterprises’ attempt to provide sustainability information to audiences in need. We will discuss the latest development in international standard on sustainability disclosure. We will diagnose the challenges on implementation and effort to resolve them. We will compare the requirements and latest development across different jurisdictions and possible cross learning among them. To conclude, we will land on what opportunities present to the actuarial community! At the end of this session, participants will be able to: • Discover requirements on sustainability reporting standards across different jurisdictions • Appreciate the challenges and progress to integrate climate risks in company’s ERM approaches • Comprehend actuaries’ opportunities and responsibilities to contribute

Description: Session 8E: Cowboy Up - Strengthening ACA Rule Enforcement in Texas and the Dusty Trail to 2026